We spoke with Mike Hilton, property adviser for Phoenix Spree Deutschland (PSDL), the property group specialising in the Berlin residential market. Floated on the London Stock Exchange in June 2015, Phoenix has already accumulated a portfolio worth €400m (£336m) and is well placed to take advantage of the ever increasing demand for rental properties in Berlin.

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

Ethical funds might just surprise you. They can pay higher income than you'd expect and generate healthy returns. However, they might invest in stocks you're not so keen on too... This week's Personal Finance Show takes a look at when ethical funds aren't so ethical and looks at why some of them are outperforming.The team also tackles how to beat miserly interest rates by moving away from cash and into the market and also looks at why investment trust IPOs are back in fashion. Deputy personal finance editor Kate Beioley is joined by Andrew Summers, head of fund research at Investec Wealth and Emma Agyemang, Investors Chronicle personal finance writer.

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

IC editor John Hughman is joined by Ian Smith and Megan Boxall from the companies team to discuss the week's big market news, including troubles in the telco sector, turnaround potential at Pearson and a big drug trial success at AstraZeneca.Apologies for the lateness of the podcast – we had to re-record it after some technical glitches in the studio yesterday.

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

Bacanora Minerals (AIM:BCN), the only pure-play lithium miner listed in London, is "100 per cent" focused on securing financing for its lithium carbonate project in Sonora, Mexico by the end of 2017. So what is it now doing on the German-Czech border?For the latest extraction podcast, natural resources writer Alex Newman visited Zinnwald in Saxony, to see Bacanora's new project with Solar World and speak to chief executive Peter Secker about Sonora, German chemicals and surging lithium demand.

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

In this week's personal finance show the team look at what has been driving Artemis Global Income fund's returns, and profile some ETFs which try to eliminate the dangers of equity income. They also discuss ways to make your pension pot last through your retirement.They are joined by Rosie Bullard, portfolio manager at James Hambro & Partners.

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

In this week's companies and markets podcast IC editor John Hughman chats with Megan Boxall about the companies working on cures for his rock star lifestyle, and Harriet Russell about the improving fortunes of the grocery retail industry.Produced by Alex Newman.

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

Provident Financial enjoyed years of share price growth driven by its credit card subsidiary subsidiary Vanquis Bank. But its stock finished lower in 2016 as bookings fell and domestic economic concerns weighed. CEO Peter Crook talks with companies editor Ian Smith about a stronger start to 2017, and operational changes in the group's doorstep lending business.Provident's shares trade at a fairly hefty premium to their historic price-to-earnings ratio. Given the costs of growth, concerns about the UK economy and the potential disruption of its restructure - not to mention a regulatory review - should investors be nervous about its prospects?

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

In this week's personal finance podcast the team highlight some of the risks facing UK equity income, and the merits of overseas equity income. They also update on Baillie Gifford Japan Trust and highlight some of the risks of taking advantage of pensions freedoms.

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

Companies editor Ian Smith and guests discuss the latest ructions for energy companies alongside our review of Aim's top stocks including a look at BooHoo vs Asos and some of Aim's favourite oil stocks

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

Drug pricing always comes with political noise, particularly when US elections are concerned. Over the last year, the share prices of pharmaceutical and biotech companies on both sides of the Atlantic have continually swung on the tweets and proclamations of politicians.In this special podcast, IC companies writer Megan Boxall speaks with industry insiders and tries to cut through the controversy and policy rumblings, to assess whether there are still good reasons to view pharma and biotech companies as worthwhile investments. Produced by Alex Newman and Dominic Toms, with music from Blue Dot Sessions. News clips courtesy of Fox.

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.